NEW YORK (GenomeWeb) – A team led by researchers at University College Dublin has developed a model of the c-JUN N-terminal kinase (JNK) protein signaling network that can serve as a biomarker for predicting survival in neuroblastoma patients.
NEW YORK (GenomeWeb) – A team led by researchers at University College Dublin has developed a model of the c-JUN N-terminal kinase (JNK) protein signaling network that can serve as a biomarker for predicting survival in neuroblastoma patients.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.